Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BlodLab Nordic AB
AB
Active
Org 5594448465
Skeppsmäklargatan 49
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 0
EBITDA margin
—
-218% vs 2024
Equity ratio
11.6%
Financial strength
Net profit 2025
SEK -117K
-394% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 0
—
EBITDA
SEK -69K
-218%
Net profit
SEK -117K
-394%
Total assets
SEK 222K
+67%
Equity
SEK 26K
+1982%
Employees
0
—
Company information
Legal name
BlodLab Nordic AB
Org number
5594448465
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 augusti 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget kommer vara verksamt inom områdena testning och analys av blod och därmed förenlig verksamhet.
Contact
Address
Skeppsmäklargatan 49
Email
fahrije.bajrami@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
−1
0
Staff expenses
−11
−0
EBITDA
−22
−69
Depreciation & amort.
−2
−49
EBIT
−24
−117
Net financials
—
−0
Profit before tax
−24
−117
Tax
—
—
Net profit
−24
−117
Balance sheet
SEK thousands
Item
2024
2025
Total assets
133
222
Equity
1
26
Long-term debt
—
—
Short-term debt
131
196
Total debt
131
196
Financial ratios
5-year trend
EBITDA margin
-6892700.0%
This company
15.8%
Market median
-43624784% vs market
2024
2025
Equity ratio
11.6%
This company
38.2%
Market median
-70% vs market
2024
2025
Return on equity
-455.3%
This company
18.4%
Market median
-2574% vs market
2024
2025
Net profit margin
-11744600.0%
This company
8.1%
Market median
-144995162% vs market
2024
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2025
Debt / equity
7.60×
This company
0.62×
Market median
-1126% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-17 – 2024-02-29
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
YA
Yahya Asghary
Chief Executive Officer
Chief Executive Officer
2023 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
BS
Berus Sefdin Aydal
Deputy Board Member
2023
SK
Sepideh Khakbaz
Board of Directors
2025
FB
Fahrije Bajrami
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BlodLab Nordic AB also hold positions in
0
other companies.
Person
Role here
Other companies
Yahya Asghary
Chief Executive Officer
0 companies
Berus Sefdin Aydal
Deputy Board Member
0 companies
Sepideh Khakbaz
Board of Directors
0 companies
Fahrije Bajrami
Chairman
0 companies